Gabather AB (publ) (GABA.ST)

SEK 0.04

(-6.88%)

Inventory Summary of Gabather AB (publ)

  • Gabather AB (publ)'s latest annual inventory in 2023 was -1772.00 SEK , down -312.09% from previous year.
  • Gabather AB (publ)'s latest quarterly inventory in 2024 Q2 was -1.31 Million SEK , up 100.0% from previous quarter.
  • Gabather AB (publ) reported annual inventory of -430.00 SEK in 2022, up 13.13% from previous year.
  • Gabather AB (publ) reported annual inventory of -495.00 SEK in 2021, down -93.36% from previous year.
  • Gabather AB (publ) reported quarterly inventory of -1.31 Million SEK for 2024 Q2, up 100.0% from previous quarter.
  • Gabather AB (publ) reported quarterly inventory of -1772.00 SEK for 2023 FY, down -312.09% from previous quarter.

Annual Inventory Chart of Gabather AB (publ) (2023 - 2014)

Historical Annual Inventory of Gabather AB (publ) (2023 - 2014)

Year Inventory Inventory Growth
2023 -1772.00 SEK -312.09%
2022 -430.00 SEK 13.13%
2021 -495.00 SEK -93.36%
2020 -256.00 SEK 34.02%
2019 -388.00 SEK 99.95%
2018 -720.23 Thousand SEK 26.11%
2017 -974.73 Thousand SEK 96.5%
2016 -27.88 Million SEK -25245.72%
2015 -110.03 Thousand SEK 0.0%
2014 - SEK 0.0%

Peer Inventory Comparison of Gabather AB (publ)

Name Inventory Inventory Difference
AcuCort AB -1.09 Million SEK 99.839%
AlzeCure Pharma AB (publ) -2508.00 SEK 29.346%
BioGaia AB (publ) 181.2 Million SEK 100.001%
Enzymatica AB (publ) 11.49 Million SEK 100.015%
Enorama Pharma AB (publ) 4.29 Million SEK 100.041%
Klaria Pharma Holding AB (publ.) - SEK Infinity%
Moberg Pharma AB (publ) 7.11 Million SEK 100.025%
Nanexa AB (publ) 1.91 Million SEK 100.093%
Newbury Pharmaceuticals AB (publ) 4.99 Million SEK 100.035%
ODI Pharma AB - SEK Infinity%
Orexo AB (publ) 42.4 Million SEK 100.004%
Probi AB (publ) 116.7 Million SEK 100.002%
Swedencare AB (publ) 398.1 Million SEK 100.0%
Swedish Orphan Biovitrum AB (publ) 3.87 Billion SEK 100.0%
Toleranzia AB -1.34 Million SEK 99.868%
Vivesto AB - SEK Infinity%